| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics
|
Meador, Siena
|
|
|
53 |
2 |
p. 436-445
|
artikel
|
| 2 |
Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation
|
Li, Ray J.
|
|
|
53 |
2 |
p. 425-435
|
artikel
|
| 3 |
Atypical late diagnosis of Noonan syndrome revealed by bleedings due to platelet dysfunction
|
Fiore, Mathieu
|
|
|
53 |
2 |
p. 557-560
|
artikel
|
| 4 |
Background of fatal pulmonary embolism: an analysis of all diagnosed fatal pulmonary embolism in 2015–2018 from Hospital District of Helsinki and Uusimaa
|
Antero, Sane Markus
|
|
|
53 |
2 |
p. 550-556
|
artikel
|
| 5 |
Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration
|
Long, Clayton V.
|
|
|
53 |
2 |
p. 359-362
|
artikel
|
| 6 |
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis
|
Pasha, Ahmed K.
|
|
|
53 |
2 |
p. 454-466
|
artikel
|
| 7 |
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
|
Cacciola, Rossella
|
|
|
53 |
2 |
p. 282-290
|
artikel
|
| 8 |
Circ_0003204 knockdown protects endothelial cells against oxidized low-density lipoprotein-induced injuries by targeting the miR-491-5p-ICAM1 pathway
|
Zhang, Dongying
|
|
|
53 |
2 |
p. 302-312
|
artikel
|
| 9 |
Clinical outcomes of surgical embolectomy versus catheter-directed thrombolysis for acute limb ischemia: a nationwide cohort study
|
Yang, Po-Kai
|
|
|
53 |
2 |
p. 517-522
|
artikel
|
| 10 |
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
|
Potere, Nicola
|
|
|
53 |
2 |
p. 346-351
|
artikel
|
| 11 |
Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study
|
Benzidia, Ilham
|
|
|
53 |
2 |
p. 417-424
|
artikel
|
| 12 |
Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study
|
Rodrigues, Thays C. R.
|
|
|
53 |
2 |
p. 390-398
|
artikel
|
| 13 |
Efficacy of prothrombin complex concentrate in the management of oral factor Xa inhibitors associated major bleed assessed by ISTH and ANNEXA-4 criteria
|
Dev, Pallavi
|
|
|
53 |
2 |
p. 249-256
|
artikel
|
| 14 |
Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis
|
Goh, Sherill
|
|
|
53 |
2 |
p. 485-494
|
artikel
|
| 15 |
Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19
|
Farrar, Julie E.
|
|
|
53 |
2 |
p. 446-453
|
artikel
|
| 16 |
Fibrinspecific liposomes as a potential method of delivery of the thrombolytic preparation streptokinase
|
Adzerikho, I. E.
|
|
|
53 |
2 |
p. 313-320
|
artikel
|
| 17 |
Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges
|
Zaaqoq, Akram M.
|
|
|
53 |
2 |
p. 499-505
|
artikel
|
| 18 |
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry)
|
Kiris, Tuncay
|
|
|
53 |
2 |
p. 321-334
|
artikel
|
| 19 |
Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid
|
Paredes-Ruiz, Diana
|
|
|
53 |
2 |
p. 471-478
|
artikel
|
| 20 |
Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study
|
Yu, Xinge
|
|
|
53 |
2 |
p. 291-301
|
artikel
|
| 21 |
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
|
Usman, Abira
|
|
|
53 |
2 |
p. 363-371
|
artikel
|
| 22 |
One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy
|
De Luca, Leonardo
|
|
|
53 |
2 |
p. 410-416
|
artikel
|
| 23 |
One-year outcomes of patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic
|
Phua, Kailun
|
|
|
53 |
2 |
p. 335-345
|
artikel
|
| 24 |
Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals
|
Sebolt, Jonathan
|
|
|
53 |
2 |
p. 257-263
|
artikel
|
| 25 |
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI
|
Cao, Davide
|
|
|
53 |
2 |
p. 380-389
|
artikel
|
| 26 |
Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry
|
Hata, Reo
|
|
|
53 |
2 |
p. 540-549
|
artikel
|
| 27 |
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
|
Abosheasha, Mohammed A.
|
|
|
53 |
2 |
p. 273-281
|
artikel
|
| 28 |
Potent platelet inhibition with peri-procedural tirofiban may attenuate progression of atherosclerosis in patients with acute coronary syndromes
|
Nakajima, Akihiro
|
|
|
53 |
2 |
p. 241-248
|
artikel
|
| 29 |
Predicting factors for pulmonary embolism response team activation in a general pulmonary embolism population
|
Mortensen, Christian Schmidt
|
|
|
53 |
2 |
p. 506-513
|
artikel
|
| 30 |
Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
|
Kuno, Toshiki
|
|
|
53 |
2 |
p. 352-358
|
artikel
|
| 31 |
Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score
|
Chen, Jindong
|
|
|
53 |
2 |
p. 523-531
|
artikel
|
| 32 |
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study
|
Goldhaber, Samuel Z.
|
|
|
53 |
2 |
p. 399-409
|
artikel
|
| 33 |
Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma
|
Thomas, Alissa A.
|
|
|
53 |
2 |
p. 479-484
|
artikel
|
| 34 |
Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006–2012)
|
Ammann, Eric M.
|
|
|
53 |
2 |
p. 264-272
|
artikel
|
| 35 |
Sickle cell disease related chronic thromboembolic pulmonary hypertension: challenging clinical scenario
|
Karyofyllis, Panagiotis
|
|
|
53 |
2 |
p. 467-470
|
artikel
|
| 36 |
Thrombotic superior vena cava syndrome: a national emergency department database study
|
Mir, Tanveer
|
|
|
53 |
2 |
p. 372-379
|
artikel
|
| 37 |
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment
|
Galli, Mattia
|
|
|
53 |
2 |
p. 495-498
|
artikel
|
| 38 |
Uncertainties about platelet function and genetic testing for guiding dual antiplatelet therapy in percutaneous coronary intervention
|
Condello, Francesco
|
|
|
53 |
2 |
p. 514-516
|
artikel
|
| 39 |
Vitamin D levels and C-reactive protein/albumin ratio in pregnant women with cerebral venous sinus thrombosis
|
Yevgi, Recep
|
|
|
53 |
2 |
p. 532-539
|
artikel
|
Tijdschrift beschrijving